210
Participants
Start Date
October 15, 2015
Primary Completion Date
September 20, 2017
Study Completion Date
November 13, 2017
Dupilumab
Solution for injection, Subcutaneous injection in the abdomen, upper thigh or upper arm.
Placebo
Solution for injection, Subcutaneous injection in the abdomen, upper thigh or upper arm.
Oral corticosteroid therapy (prednisone/prednisolone)
Oral administration.
Inhaled corticosteroid (ICS) therapy
Oral inhalation, stable dose (high dose) of ICS in combination with up to 2 other controller medicines (second or third controller therapy).
Albuterol/Salbutamol
Oral inhalation as needed.
Levalbuterol/Levosalbutamol
Oral inhalation as needed.
Investigational Site Number 056002, Brussels
Investigational Site Number 348301, Balassagyarmat
Investigational Site Number 056001, Leuven
Investigational Site Number 348303, Edelény
Investigational Site Number 056003, Ghent
Investigational Site Number 840010, Pittsburgh
Investigational Site Number 724096, Santiago de Compostela
Investigational Site Number 380002, Genova
Investigational Site Number 804019, Vinnytsia
Investigational Site Number 724006, Pozuelo de Alarcón
Investigational Site Number 724013, Madrid
Investigational Site Number 484013, Chihuahua City
Investigational Site Number 376003, Haifa
Investigational Site Number 804002, Poltava
Investigational Site Number 484016, Acapulco
Investigational Site Number 380003, Reggio Emilia
Investigational Site Number 484001, Guadalajara
Investigational Site Number 376001, Kfar Saba
Investigational Site Number 376005, Petah Tikva
Investigational Site Number 376004, Tel Litwinsky
Investigational Site Number 380001, Pisa
Investigational Site Number 804007, Chernivtsi
Investigational Site Number 804001, Kharkiv
Investigational Site Number 840002, St Louis
Investigational Site Number 484003, Monterrey
Investigational Site Number 804006, Odesa
Investigational Site Number 840070, McKinney
Investigational Site Number 840128, McKinney
Investigational Site Number 840118, Plano
Investigational Site Number 804004, Ivano-Frankivsk
Investigational Site Number 804009, Ivano-Frankivsk
Investigational Site Number 376002, Rehovot
Investigational Site Number 840062, Amarillo
Investigational Site Number 380008, Napoli
Investigational Site Number 840022, Los Angeles
Investigational Site Number 380009, Palermo
Investigational Site Number 840014, Rolling Hills Estates
Investigational Site Number 380005, Catania
Investigational Site Number 643006, Moscow
Investigational Site Number 170001, Bogotá
Investigational Site Number 643007, Moscow
Investigational Site Number 643099, Saint Petersburg
Investigational Site Number 643011, Saint Petersburg
Investigational Site Number 643009, Saint Petersburg
Investigational Site Number 642105, Timișoara
Investigational Site Number 642106, Timișoara
Investigational Site Number 642102, Cluj-Napoca
Investigational Site Number 642107, Cluj-Napoca
Investigational Site Number 642108, Cluj-Napoca
Investigational Site Number 152007, Quillota
Investigational Site Number 152008, Talca
Investigational Site Number 152005, Santiago
Investigational Site Number 032003, Buenos Aires
Investigational Site Number 032001, Caba
Investigational Site Number 032091, Caba
Investigational Site Number 076013, São Bernardo do Campo
Investigational Site Number 076011, São Paulo
Investigational Site Number 076002, Sorocaba
Investigational Site Number 124009, Calgary
Investigational Site Number 124016, Hamilton
Investigational Site Number 124003, Mississauga
Investigational Site Number 124013, Ottawa
Investigational Site Number 124002, Toronto
Investigational Site Number 124017, Vancouver
Investigational Site Number 170006, Bogotá
Investigational Site Number 484002, Mexico City
Investigational Site Number 528001, Arnhem
Investigational Site Number 528002, Dordrecht
Investigational Site Number 616006, Bialystok
Investigational Site Number 616097, Krakow
Investigational Site Number 616001, Lodz
Investigational Site Number 616010, Warsaw
Investigational Site Number 616011, Żnin
Investigational Site Number 642104, Bucharest
Investigational Site Number 642103, Bucharest
Investigational Site Number 724014, Barcelona
Investigational Site Number 724002, Barcelona
Investigational Site Number 724007, Sant Boi de Llobregat
Investigational Site Number 804003, Kyiv
Investigational Site Number 804011, Kyiv
Lead Sponsor
Regeneron Pharmaceuticals
INDUSTRY
Sanofi
INDUSTRY